31 – 40 of 1021
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
(
- Contribution to journal › Article
-
Mark
The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases : Mariana Reste1† , Kristi Ajazi 2† , Ayca Sayi-Yazgan3,4, Radmila Jankovic 5 , Biljana Bufan6 , Sven Brandau7 , Espen S. Bækkevold 8 , Florent Petitprez 9 , Malin Lindstedt 2 *, Gosse J. Adema10* and Catarina R. Almeida1 *
(
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
(
- Contribution to journal › Article
-
Mark
Automated multiplexed affinity-based enrichment of peptides for LC-MS/MS plasma proteomics
(
- Contribution to journal › Article
-
Mark
Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients
(
- Contribution to journal › Article
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
(
- Contribution to journal › Scientific review
-
Mark
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
(
- Contribution to journal › Article
-
Mark
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
(
- Contribution to journal › Article
-
Mark
WOMBAT-P : Benchmarking Label-Free Proteomics Data Analysis Workflows
(
- Contribution to journal › Article